SubHero Banner
Text

2nd Quarter 2016

Key topics in this quarter’s edition include:

  • Xultophy® (insulin degludec/liraglutide) for the treatment of type 2 diabetes mellitus
  • Atezolizumab for the treatment of bladder cancer and non-small cell lung cancer

Download PDF

Text